Not all patients with CLL require therapy. Irrespective of all recent developments, the iwCLL however suggests watchful observation for people with asymptomatic sickness.86 This recommendation relies on at the very least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Partisipasi aktif dari masyarakat https://marjaneyg333xqh3.thelateblog.com/profile